A green approach for preparation of polyacrylic acid/starch incorporated with titanium dioxide nanocomposite as a biocompatible platform for curcumin delivery to breast cancer cells

Multifunctional Polymeric Bioactive Coatings on Ti Implants through the Drug Delivery Approach: In Vitro Corrosion Resistance, Biocompatibility, and Antibacterial Characteristics

In the current study, we developed a controlled drug delivery system using a polymeric matrix composed of biopolymer poly(vinylidene fluoride) (PVDF) and ciprofloxacin (CPF)-loaded titanium (Ti) nanotubes (TNTs) on Ti substrates for biomedical applications. The TNT arrays over the Ti surface were obtained through an anodization route. The PVDF coatings were dip-coated on TNT-Ti loaded with CPF. The chemical, microstructure, and surface properties of the TNTs and coated surfaces were characterized using FTIR, XRD, transmission electron microscopy (TEM), scanning electron microscopy (SEM)/energy-dispersive X-ray spectroscopy (EDS), and surface hydrophilicity analyses. The performance of the implant surfaces was evaluated through in vitro corrosion studies in simulated body fluid (SBF), biocompatibility with MG63 cells, and antibacterial properties. The results revealed that the PVDF/0.1CPF coatings exhibited sustained release of CPF from the polymer matrix at a linear rate and releasing profile for 168 h. PVDF/0.1CPF coating showed decreased corrosion current density (4.457 × 10-9 A/cm2) by 2 orders of magnitude than that of the Ti substrate, indicating enhanced corrosion protection in the SBF. PVDF/0.1CPF coating showed an antibacterial efficacy of 84.44% against Escherichia coli and 88.33% against Bacillus licheniformis after 24 h. The biocompatibility result showed that after 5 days of culturing, the PVDF/0.1CPF was pointedly higher than that of the pure PVDF and uncoated specimens. Additionally, after 7 days of culture, the quantity of cells on the PVDF/0.1CPF coating continued to increase significantly, whereas the bare specimens and pristine PVDF showed a lower rate of proliferation. The proposed biocompatible polymeric coatings hold synergic antibacterial and corrosion-resistant potential for biomedical applications.

Synthesis, characterization, and applications of starch-based nano drug delivery systems for breast cancer therapy: A review

The review examined the potential of starch-based drug delivery systems for managing breast cancer efficiently. It covered the background of breast cancer and the significance of drug delivery systems in treatment enhancement. Starch, known for its versatile physicochemical properties, was explored as a promising biopolymer for drug delivery. The review detailed the properties of starch relevant to drug delivery, synthesis methods, and characterization approaches. It discussed the application of starch-based systems in breast cancer treatment, focusing on their role in improving chemotherapy delivery. The advantages and limitations of these systems, such as biocompatibility and drug loading capacity, were evaluated, along with future research directions in starch modification and emerging technologies. The review concluded by emphasizing the potential of starch-based drug delivery systems in improving breast cancer treatment outcomes.

Targeted delivery of quercetin using gelatin/starch/Fe3O4 nanocarrier to suppress the growth of liver cancer HepG2 cells

To suppress HepG2 liver cancer cells, a nanocarrier (NC) consisting of Fe3O4, Gelatin (G), and Starch (S) was synthesized and characterized for targeted delivery of Quercetin (QC) drug. The spectra obtained from X-ray diffraction (XRD) and Fourier transform infrared (FTIR) demonstrated that the nanoparticles (NP) in the NC are well-interconnected to each other and have formed a regular structure. Also, field emission scanning electron microscopy (FE-SEM) indicates a smooth and homogeneous surface of the synthesized NC. The results of the vibrating sample magnetometer (VSM) also corroborated the correctness of the synthesis of Fe3O4 NPs and Gelatin/Starch/Fe3O4@Quercetin NC (G/S/Fe3O4@QC) because the magnetic properties of Fe3O4 decreased with the addition of G/S@QC. Stability and particle size were determined by zeta potential and Dynamic light scattering (DLS). The percentage of drug loading and encapsulation efficiency of QC in the NC was 46.25 % and 87 %, respectively. QC profile release in acidic and natural environments showed controlled release and pH sensitivity of the NC. Cytotoxicity of L929 and HepG2 treated cells with the G/S/Fe3O4@QC was investigated by MTT staining, which agreed with the flow cytometry result. The results of Flowcytometry and MTT showed 43.5 % apoptosis and 42 % cytotoxicity in treated HepG2 cells by G/S/Fe3O4@QC, while it was not toxic to L929 normal cells. According to the results, G/S/Fe3O4@QC is a suitable NC for the targeted delivery of QC as a drug against HepG2 cancer cells.

Curcumin Administration Routes in Breast Cancer Treatment

Breast cancer is a public health concern worldwide, characterized by increasing incidence and mortality rates, requiring novel and effective therapeutic strategies. Curcumin is a bioactive compound extracted from turmeric with several pharmacological activities. Curcumin is a multifaceted anticancer agent through mechanisms including the modulation of signaling pathways, inhibition of cell proliferation, induction of apoptosis, and production of reactive oxygen species. However, the poor water solubility and bioavailability of curcumin create important barriers in its clinical application. This review elaborates on the therapeutic potential of curcumin in breast cancer treatment, focusing on the efficacy of different administration routes and synergistic effects with other therapeutic agents. The intravenous administration of curcumin-loaded nanoparticles significantly improves bioavailability and therapeutic outcomes compared to oral routes. Innovative formulations, such as nano-emulsifying drug delivery systems, have shown promise in enhancing oral bioavailability. While intravenous delivery ensures higher bioavailability and direct action on tumor cells, it is more invasive and expensive than oral administration. Advancing research on curcumin in breast cancer treatment is essential for improving therapeutic outcomes and enhancing the quality of life of patients.

Formulation of lactoferrin decorated dextran based chitosan-coated europium metal-organic framework for targeted delivery of curcumin

Hepatocellular carcinoma (HPTC) currently ranks as the third leading cause of cancer-related mortality, necessitating an advanced formulation strategy. Recently, lactoferrin (Lf) has been utilized as a specific targeting ligand in HPTC due to its high specificity towards the asialoglycoprotein receptor expressed in cancer cells. Therefore, we present the fabrication of an Lf-decorated carboxymethyl dextran-encased chitosan-coated europium metal-organic framework-based nanobioconjugate (Lf-CMD-CS-CUR@Eu-MOF) for targeted curcumin (CUR) delivery. Briefly, CUR was loaded into Eu-MOF, followed by coating cationic 'CS' on the CUR@Eu-MOF surface. Simultaneously, Lf-decorated CMD was prepared via an esterification reaction. Subsequently, Lf-CMD-CS-CUR@Eu-MOF was synthesized using the Maillard reaction. Various spectral characterizations, drug entrapment, drug content, in vitro drug release, biocompatibility and cell cytotoxicity studies were performed. It exhibited an entrapment efficiency of 88.87 ± 2.1 %, a drug content of 3.45 ± 0.98 %, and a drug loading rate of 34.85 ± 0.6 mg/g. Furthermore, the Lf-CMD-CS-CUR@Eu-MOF exhibits excellent biocompatibility with normal cells. The in vitro dissolution study confirmed a release of 78.12 % of 'CUR' in pH 5.8 phosphate buffer (over 120 h), attributed to the controlled release rate by the 'CS' coating on the surface of CUR@Eu-MOF. The BEL-7402 cell line showed concentration-dependent toxicity of nanobioconjugate to cancerous cells. Therefore, when 'Lf' is surface-decorated onto an appropriate polymeric material, it gains the capability to function as a carrier for transporting 'CUR' to the precise target site within HPTC. In conclusion, Lf-CMD incorporated CS-coated Eu-MOF can provide a promising approach for targeted drug delivery in HPTC management.

Synthesis & fabrication of O-linked polymeric hybrids for recovery of textile dyes: Closed loop economy

Dyes are an important resource employed for the production systems in textile, paper, paint and leather industry. An estimate of 200,000 tons of dyes are discharged as textile effluent each year worldwide. It becomes imperative to recover these dyes by treating the effluents using economically viable routes. The present research was undertaken with the objective to attain zero emission and zero waste through development of novel polymeric hybrids as adsorbents. For this purpose, metal moieties (Al3+, Si4+, Ti4+ and Zr4+) were hybridized with polyacrylic acid, and cellulose acetate for the uptake of selected dyes under optimized parameters. The structural elucidation of four synthesized hybrids (MP-Al, MP-Si, MP-Ti and MP-Zr) by FTIR, EDX and TGA confirmed O-linked grafting of metal moieties with polymers and thermally stable porous materials. SEM micrographic images displayed void spaces providing channels for effective adsorption. The batch experiments demonstrated removal of malachite green (77-96%) and congo red (70-82%) upon contact of initial 45 min on polymeric hybrids On the other hand, pristine polyacrylic acid and cellulose acetate showed remarkably low removal of dyes. The adsorption mechanism is proposed as physical in nature following type II isotherm. Further, Langmuir and Ho's pseudo second order fitness was evaluated. In order to determine the economic viability of the present research, the real textile dyes were recovered in three consecutive cycles of adsorption and chemical treatment of hybrids. The results propose a system with positive impact on economy by maximum utilization of hybrids as adsorbents and recovery of textile dyes for reuse in textile processing.

Synthesis and characterization of chitosan/carbon quantum dots/Fe2O3 nanocomposite comprising curcumin for targeted drug delivery in breast cancer therapy

Curcumin, a natural compound with promising anti-cancerous features, suffers from a number of shortcomings such as low chemical stability, bioavailability, and solubility, which impedes its application as an alternative for conventional cancer therapy. In this study, curcumin comprising Fe2O3/Chitosan/CQDs was fabricated through double emulsion method (W/O/W) for the first time to exploit its anticancer features while alleviating its limitation, making this nanocomposite promising in targeted drug delivery. Chitosan, a hydrophilic biopolymer, has incorporated to constitute an adhesive pH-sensitive matrix that can trap the hydrophobic drug resulting in controlled drug release in cancerous environment. Carbon quantum dots render luminescence and water solubility properties, which is favorable for tracing drug release and bio imaging along with enhancement of biocompatibility. Fe2O3 can improve chemical stability and bioavailability in addition to anti-cancerous property. XRD and FTIR analysis confirmed the physical interaction between the drug and fabricated nano composite in addition to chemical bonding between the prepared nano composite. Matrix and spherical structure of the formed drug is corroborated by FESEM analysis. DLS analysis' results determine the mean size of the nano composite at about 227.2 nm and zeta potential result is indicative of perfect stability of the fabricated drug. Various kinetic models for drug release were fitted to experimental data in order to investigate the drug release in which Korsmeyer-Peppas' model was the predominant release system in cancerous environment. In vitro studies through flow cytometry and MTT assay exerted noticeable cytotoxicity effect on MCF-7 cell lines. It can be deduced from these results that curcumin encapsulated with CS/CQDs/Fe2O3 nanocomposites is an excellent alternative for targeted drug delivery.

Mass Spectrometry Imaging of Biomaterials

The science related to biomaterials and tissue engineering accounts for a growing part of our knowledge. Surface modifications of biomaterials, their performance in vitro, and the interaction between them and surrounding tissues are gaining more and more attention. It is because we are interested in finding sophisticated materials that help us to treat or mitigate different disorders. Therefore, efficient methods for surface analysis are needed. Several methods are routinely applied to characterize the physical and chemical properties of the biomaterial surface. Mass Spectrometry Imaging (MSI) techniques are able to measure the information about molecular composition simultaneously from biomaterial and adjacent tissue. That is why it can answer the questions connected with biomaterial characteristics and their biological influence. Moreover, this kind of analysis does not demand any antibodies or dyes that may influence the studied items. It means that we can correlate surface chemistry with a biological response without any modification that could distort the image. In our review, we presented examples of biomaterials analyzed by MSI techniques to indicate the utility of SIMS, MALDI, and DESI-three major ones in the field of biomaterials applications. Examples include biomaterials used to treat vascular system diseases, bone implants with the effects of implanted material on adjacent tissues, nanofibers and membranes monitored by mass spectrometry-related techniques, analyses of drug-eluting long-acting parenteral (LAPs) implants and microspheres where MSI serves as a quality control system.